SEAWAY PHARMA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at SEAWAY PHARMA is $62,000, based on 25 certified filings from FY 2020 to FY 2025. This is 48% lower than the national H-1B median salary of $120,000. Compensation at SEAWAY PHARMA reflects their market positioning, with entry-level roles starting around $56,000 and senior positions reaching $80,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at SEAWAY PHARMA range from $55,000 at the 10th percentile to $80,000 at the 90th percentile, showing a $25,000 spread across experience levels and roles. The 25th percentile is $56,000 and the 75th percentile is $68,619.

Yes, SEAWAY PHARMA actively sponsors H-1B visas in FY 2025. In the most recent fiscal year (FY 2025), SEAWAY PHARMA filed 3 H-1B labor condition applications with 3 certified and 0 denied, at a median salary of $64,397. Across FY 2020–2025, they have filed 25 total H-1B applications with 25 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. SEAWAY PHARMA sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), SEAWAY PHARMA filed 3 H-1B applications, with 3 certified and 0 denied. Over 6 years of data, SEAWAY PHARMA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

SEAWAY PHARMA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 25 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating SEAWAY PHARMA as a potential H-1B sponsor.

This is an excellent approval rate, indicating SEAWAY PHARMA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

SEAWAY PHARMA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 25 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles SEAWAY PHARMA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at SEAWAY PHARMA:

The most frequently sponsored role is Chemist with 15 filings at a median salary of $60,000. This is followed by Senior Chemist (2 filings) and Financial Analyst.

SEAWAY PHARMA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where SEAWAY PHARMA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top SEAWAY PHARMA H-1B locations:

The largest H-1B hub for SEAWAY PHARMA is Massena, NY with 23 filings at a median salary of $62,000. The highest-paying location is North Bergen, NJ at $82,285 median. Salaries range from $62,000 to $82,285 across office locations.

SEAWAY PHARMA's median H-1B salary has changed by -6% from FY 2020 ($68,619) to FY 2025 ($64,397). Tracking salary trends over time reveals how SEAWAY PHARMA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at SEAWAY PHARMA.

Year-by-year breakdown:

• FY 2021: $78,062 (3 certified)
• FY 2022: $67,808 (4 certified)
• FY 2023: $55,000 (5 certified)
• FY 2024: $64,480 (4 certified)
• FY 2025: $64,397 (3 certified)

Salary levels have remained relatively stable at SEAWAY PHARMA.

SEAWAY PHARMA primarily files H-1B applications at Wage Level I, accounting for 64% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making SEAWAY PHARMA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

A significant portion of SEAWAY PHARMA's H-1B filings are at entry-level (Level I) wages. These positions may face more competition in the H-1B lottery.

SEAWAY PHARMA's median H-1B salary of $62,000 is 48% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating SEAWAY PHARMA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare SEAWAY PHARMA's offerings with similar companies in your field for a more accurate assessment.

SEAWAY PHARMA's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. SEAWAY PHARMA files 64% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 25 certified filings, SEAWAY PHARMA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.